Correlation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation

References

• Trojnar M, Patro-Malysza J, Kimber-Trojnar Z, Leszczynska-Gorzelak B, Mosiewicz J. Association between fatty acid-binding protein 4-A proinflammatory adipokine and insulin resistance, gestational and type 2 diabetes mellitus. Cells. 2019;8(3):E227. doi:10.3390/cells8030227
   PubMed Web of Science ®Google Scholar
• Elsehmawy AAEW, El-Toukhy SE, Seliem NMA, Moustafa RS, Mohammed DS. Apelin and chemerin as promising adipokines in children with type 1 diabetes mellitus. Diabetes Metab Syndr Obes. 2019;12:383–389. doi:10.2147/DMSO.S189264
   PubMed Web of Science ®Google Scholar
• Lelis DF, Freitas DF, Machado AS, Crespo TS, Santos SHS. Angiotensin-(1–7), adipokines and inflammation. Metabolism. 2019;95:36–45. doi:10.1016/j.metabol.2019.03.006
   PubMed Web of Science ®Google Scholar
• Shen HH, Yang CY, Kung CW, et al. Raloxifene inhibits adipose tissue inflammation and adipogenesis through Wnt regulation in ovariectomized rats and 3 T3-L1 cells. J Biomed Sci. 2019;26(1):62. doi:10.1186/s12929-019-0556-3
   PubMedGoogle Scholar
• Mori H, Prestwich T, Reid MA, et al. Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J Clin Invest. 2012;122(7):2405–2416. doi:10.1172/JCI63604
   PubMed Web of Science ®Google Scholar
• Rulifson IC, Majeti JZ, Xiong Y, et al. Inhibition of secreted frizzled-related protein 5 improves glucose metabolism. Am J Physiol Endocrinol Metab. 2014;307(12):E1144–H1152. doi:10.1152/ajpendo.00283.2014
   PubMed Web of Science ®Google Scholar
• Xu W, Geng H, Liu X, et al. Wingless-type MMTV integration site family member 5a: a novel biomarker regulated in type 2 diabetes mellitus and diabetic kidney disease. J Diabetes Metab Disord. 2019;18(2):525–532. doi:10.1007/s40200-019-00461-8
   PubMedGoogle Scholar
• Li B, Yao Q, Guo S, et al. Type 2 diabetes with hypertensive patients results in changes to features of adipocytokines: leptin, irisin, LGR4 and Sfrp5. Clin Exp Hypertens. 2019;41(7):645–650. doi:10.1080/10641963.2018.1529779
   PubMed Web of Science ®Google Scholar
• Prats-Puig A, Soriano-Rodriguez P, Carreras-Badosa G, et al. Balanced duo of anti-inflammatory SFRP5 and proinflammatory WNT5A in children. Pediatr Res. 2014;75(6):793–797. doi:10.1038/pr.2014.29
   PubMedGoogle Scholar
• Qu H, Liu Q, Hu Z. Relation of plasma secreted frizzled-related protein 5 to obesity and type 2 diabetes mellitus. Chin J Endocrinol Metab. 2014;30:678–681.
   Google Scholar
• Xu Q, Wang H, Li Y, et al. Plasma Sfrp5 levels correlate with determinants of the metabolic syndrome in Chinese adults. Diabetes Metab Res Rev. 2017;33(6):e2896. doi:10.1002/dmrr.v33.6
   Google Scholar
• Zhang C, Li B, Guo S. The changes of serum Irisin and SFRP5 levels in obese patients with type 2 diabetes mellitus. Int J Endocrinol Metab. 2018;38:1–5.
   Google Scholar
• Lu YC, Wang CP, Hsu CC, et al. Circulating secreted frizzled-related protein 5 (Sfrp5) and wingless-type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev. 2013;29(7):551–556. doi:10.1002/dmrr.2426
   PubMed Web of Science ®Google Scholar
• Canivell S, Rebuffat S, Ruano EG, et al. Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls. Diabetes Metab Res Rev. 2015;31(2):212–219. doi:10.1002/dmrr.v31.2
   PubMedGoogle Scholar
• World Health Organization and International Diabetes Federation. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva: World Health Organization; 2006. Available from: https://apps.who.int/iris/handle/10665/43588. Accessed March 24, 2020.
   Google Scholar
• Fouqueray P, Pirags V, Inzucchi SE, et al. The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy. Diabetes Care. 2013;36(3):565–568. doi:10.2337/dc12-0453
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• Matsuda M. Measuring and estimating insulin resistance in clinical and research settings. Nutr Metab Cardiovasc Dis. 2010;20(2):79–86. doi:10.1016/j.numecd.2009.07.007
   PubMedGoogle Scholar
• Lv C, Jiang Y, Wang H, Chen B. Sfrp5 expression and secretion in adipocytes are up-regulated during differentiation and are negatively correlated with insulin resistance. Cell Biol Int. 2012;36(9):851–855. doi:10.1042/CBI20120054
   PubMed Web of Science ®Google Scholar
• Schulte DM, Müller N, Neumann K, et al. Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects. PLoS One. 2012;7(2):e32437. doi:10.1371/journal.pone.0032437
   PubMed Web of Science ®Google Scholar
• Carstensen-Kirberg M, Hatziagelaki E, Tsiavou A, et al. Sfrp5 associates with beta-cell function in humans. Eur J Clin Invest. 2016;46(6):535–543. doi:10.1111/eci.2016.46.issue-6
   PubMed Web of Science ®Google Scholar
• Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X. Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol. 2007;49(17):1798–1805. doi:10.1016/j.jacc.2007.01.065
   PubMed Web of Science ®Google Scholar
• Xing L, Zhang H, Majumder K, Zhang W, Mine Y. r-glutamylvaline prevents low-grade chronic inflammation via activation of a calcium-sensing receptor pathway in 3T3-L1 mouse adipocytes. J Agric Food Chem. 2019;67(30):8361–8369. doi:10.1021/acs.jafc.9b02334
   PubMedGoogle Scholar
• Farb MG, Karki S, Park SY, et al. WNT5A-JNK regulation of vascular insulin resistance in human obesity. Vasc Med. 2016;21(6):489–496. doi:10.1177/1358863X16666693
   PubMedGoogle Scholar
• Minami Y, Oishi I, Endo M, Nishita M. Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases. Dev Dyn. 2010;239(1):1–15. doi:10.1002/dvdy.21991
   PubMedGoogle Scholar
• Solinas G, Becattini B. JNK at the crossroad of obesity, insulin resistance, and cell stress response. Mol Metab. 2017;6(2):174–184. doi:10.1016/j.molmet.2016.12.001
   PubMed Web of Science ®Google Scholar
• Cho YK, Kang YM, Lee SE, et al. Effect of SFRP5 (secreted frizzled-related protein 5) on the Wnt5a (wingless-type family member 5a)-induced endothelial dysfunction and its relevance with arterial stiffness in human subjects. Arterioscler Thromb Vasc Biol. 2018;38(6):1358–1367. doi:10.1161/ATVBAHA.117.310649
   PubMed Web of Science ®Google Scholar
• Kim M-H, Jee J-H, Park S, Kim KW, Lee MK, Lee M-K. Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling. J Endocrinol. 2014;220(2):117–128. doi:10.1530/JOE-13-0381
   PubMed Web of Science ®Google Scholar
• Jiating L, Buyun J, Yinchang Z. Role of metformin on osteoblast differentiation in type 2 diabetes. Biomed Res Int. 2019;2019:9203934. doi:10.1155/2019/9203934
   PubMedGoogle Scholar